Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Jan;55(1):36–40.

Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).

M Lenzi, F B Bianchi, F Cassani, E Pisi
PMCID: PMC1535786  PMID: 6692597

Abstract

To test the hypothesis that liver membrane antibodies, found in all liver-kidney microsomal antibody (LKM) positive sera from patients with chronic active hepatitis, were directed against antigens shared by both hepatocellular endoplasmic reticulum and plasma membranes, absorption experiments have been performed using viable isolated hepatocytes and liver microsomes as antigens. Results are in agreement with the above hypothesis, LKM, which displays a restricted organ specificity, is thus able to react with antigenic determinants expressed on the liver cell surface, as it has been demonstrated for strictly organ specific antibodies directed against thyroid, adrenal and gastric parietal cell microsomes.

Full text

PDF
36

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballardini G., Landi P., Busachi C. A., Bianchi F. B., Pisi E. HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies. Clin Exp Immunol. 1981 Mar;43(3):599–604. [PMC free article] [PubMed] [Google Scholar]
  2. Blobel G., Sabatini D. D. Controlled proteolysis of nascent polypeptides in rat liver cell fractions. I. Location of the polypeptides within ribosomes. J Cell Biol. 1970 Apr;45(1):130–145. doi: 10.1083/jcb.45.1.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hopf U., Meyer zum Büschenfelde K. H., Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med. 1976 Mar 11;294(11):578–582. doi: 10.1056/NEJM197603112941103. [DOI] [PubMed] [Google Scholar]
  4. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  5. Khoury E. L., Hammond L., Bottazzo G. F., Doniach D. Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol. 1981 Aug;45(2):316–328. [PMC free article] [PubMed] [Google Scholar]
  6. Khoury E. L., Hammond L., Bottazzo G. F., Doniach D. Surface-reactive antibodies to human adrenal cells in Addison's disease. Clin Exp Immunol. 1981 Jul;45(1):48–55. [PMC free article] [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Lenzi M., Cassani F., Bianchi F. B., Franceschi C. A microELISA assay to detect anti-liver-specific protein antibodies in the sera of patients with liver diseases. J Immunol Methods. 1983 Feb 25;57(1-3):59–69. doi: 10.1016/0022-1759(83)90065-0. [DOI] [PubMed] [Google Scholar]
  9. Masala C., Smurra G., Di Prima M. A., Amendolea M. A., Celestino D., Salsano F. Gastric parietal cell antibodies: demonstration by immunofluorescence of their reactivity with surface of the gastric parietal cells. Clin Exp Immunol. 1980 Aug;41(2):271–280. [PMC free article] [PubMed] [Google Scholar]
  10. McFarlane I. G., Wojcicka B. M., Zucker G. M., Eddleston A. L., Williams R. Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol. 1977 Mar;27(3):381–390. [PMC free article] [PubMed] [Google Scholar]
  11. Meliconi R., Stancari M. V., Garagnani M., Baraldini M., Stefanini G. F., Miglio F., Gasbarrini G. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology. Clin Exp Immunol. 1983 Mar;51(3):565–571. [PMC free article] [PubMed] [Google Scholar]
  12. Naughton G. K., Eisinger M., Bystryn J. C. Antibodies to normal human melanocytes in vitiligo. J Exp Med. 1983 Jul 1;158(1):246–251. doi: 10.1084/jem.158.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rizzetto M., Bianchi F. B., Doniach D. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology. 1974 Mar;26(3):589–601. [PMC free article] [PubMed] [Google Scholar]
  14. Rizzetto M., Swana G., Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973 Nov;15(3):331–344. [PMC free article] [PubMed] [Google Scholar]
  15. Seglen P. O. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res. 1973 Dec;82(2):391–398. doi: 10.1016/0014-4827(73)90357-1. [DOI] [PubMed] [Google Scholar]
  16. Smith M. G., Williams R., Walker G., Rizzetto M., Doniach D. Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J. 1974 Apr 13;2(5910):80–84. doi: 10.1136/bmj.2.5910.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Storch W., Cossel L., Dargel R. The immunoelectron-microscopical demonstration of antibodies against endoplasmic reticulum (microsomes) in chronic aggressive hepatitis and liver cirrhosis. Immunology. 1977 Jun;32(6):941–945. [PMC free article] [PubMed] [Google Scholar]
  18. Tage-Jensen U., Arnold W., Dietrichson O., Hardt F., Hopf U., Meyer Zum Büschenfelde K. H., Nielsen J. O. Liver-cell-membrane autoantibody specific for inflammatory liver diseases. Br Med J. 1977 Jan 22;1(6055):206–208. doi: 10.1136/bmj.1.6055.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]
  20. Walton B., Simpson B. R., Strunin L., Doniach D., Perrin J., Appleyard A. J. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171–1176. doi: 10.1136/bmj.1.6019.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wolfrom C., Frommel D. Clinical relevance of liver membrane antibody in chronic liver disease of children. Clin Immunol Immunopathol. 1983 Feb;26(2):184–191. doi: 10.1016/0090-1229(83)90136-8. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES